PRLAX
Price
$16.27
Change
-$0.81 (-4.74%)
Updated
Dec 18 closing price
SLANX
Price
$25.32
Change
-$1.17 (-4.42%)
Updated
Dec 18 closing price
Ad is loading...

PRLAX vs SLANX

Header iconPRLAX vs SLANX Comparison
Open Charts PRLAX vs SLANXBanner chart's image
T. Rowe Price Latin America
Price$16.27
Change-$0.81 (-4.74%)
VolumeN/A
CapitalizationN/A
DWS Latin America Equity A
Price$25.32
Change-$1.17 (-4.42%)
VolumeN/A
CapitalizationN/A
PRLAX vs SLANX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PRLAX vs. SLANX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRLAX is a Hold and SLANX is a StrongBuy.

FUNDAMENTALS
Fundamentals
PRLAX has more cash in the bank: 321M vs. SLANX (236M). SLANX pays higher dividends than PRLAX: SLANX (3.26) vs PRLAX (2.51). PRLAX was incepted earlier than SLANX: PRLAX (31 years) vs SLANX (24 years). SLANX is a more actively managed with annual turnover of: 99.00 vs. PRLAX (32.60). SLANX has a lower initial minimum investment than PRLAX: SLANX (1000) vs PRLAX (2500). PRLAX annual gain was more profitable for investors over the last year : -20.89 vs. SLANX (-24.17). SLANX return over 5 years is better than : -8.43 vs. PRLAX (-21.88).
PRLAXSLANXPRLAX / SLANX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years24 years-
Gain YTD-22.060-25.40187%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets321M236M136%
Annual Yield % from dividends2.513.2677%
Returns for 1 year-20.89-24.1786%
Returns for 3 years6.83-1.54-444%
Returns for 5 years-21.88-8.43260%
Returns for 10 years-5.3432.46-16%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RY123.70-0.71
-0.57%
Royal Bank of Canada
VVX56.19-0.87
-1.52%
V2X
HQY91.09-2.08
-2.23%
HealthEquity
YMAB9.53-0.39
-3.93%
Y-mAbs Therapeutics
FLUX1.67-0.08
-4.57%
Flux Power Holdings